New ways to care Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale …

Sectors: Pharmaceutical

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

At Orange, you can. Orange is one of the world’s leading telecommunications operators with sales of 43.5 billion euros in 2022 and 136,000 employees worldwide at 31 December 2022, including 75,000 employees in France. The Group has a total customer base of 287 million customers worldwide at 31 December 2022, including 242 million mobile customers and 24 million fixed broadband customers. The Group is present in 26 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies under the brand Orange Business. In February 2023, the Group presented its strategic plan « Lead the …

Tags: CAC40 Sectors: Law Practice Telecoms

The RATP Group is the world's fifth largest public transport company, carrying 12 million people every day in France and around the world. It boasts unrivalled experience in design, project management, operation and maintenance of all types of urban and suburban transport, making it an industry leader called upon around the globe for its expertise. The RATP Group already operates in 12 countries through 50 subsidiaries and is stepping up its international expansion through some major projects worldwide. The RATP Group is also a strong proponent of sustainable mobility. It has the know-how to meet new service quality challenges by …

Sectors: Transport

[Automatic translation follows] “For a sustainable and carbon-free economy with #rev3” Welcome to the official page of the Hauts-de-France Region. Our community is responsible for various missions serving its six million inhabitants: * Employment and economic development * High schools, higher education and research * Transportation * Planning and sustainable development of the territory, * Management of European funds * Sport, youth, culture, health, etc. Hauts-de-France is a plural region. #Leader in the #automotive industry, the railway industry, as in agriculture, our region is also the one which attracts the most foreign investors. The youngest region in France, Hauts-de-France is …

Sectors: National and local authorities

[Automatic translation follows] The leading local commercial network in France, La Poste Groupe is organized into 4 branches of activity: Services-Mail-Parcels, Banking and Insurance, Physical and digital distributor, GeoPost/DPDGroup for international. Present in more than 49 countries, on 5 continents, it achieved a turnover of €35.39 billion in 2022 on the territory. In 2021, La Poste Groupe became the first public company to adopt the status of mission company. 4 societal commitments are now included in its statutes: • Contribute to the development and cohesion of territories • Promote social inclusion • Promote ethical, inclusive and frugal digital technology • …

Sectors: Postal services

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Pharmaceutical Companies, brings together companies in the pharmaceutical industry sector in France. Created more than 130 years ago, Leem today has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 professions, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R&D centers, …

Sectors: Startup accelerator & VC

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part …

Sectors: Biotechnology Startup accelerator & VC

Accélérateur de l'éco-transition Le cd2e, pôle d'excellence régional sur les éco-activités, accompagne les entreprises, collectivités et les filières économiques de la Région Hauts-de-France vers l'éco-transition, autrement dit la transition écologique et énergétique de l’économie régionale. Il agit dans les domaines suivants : BATIMENT DURABLE, ENERGIES RENOUVELABLES, ECONOMIE CIRCULAIRE The cd2e is a team of environmental and business experts dedicated to supporting the environmental sector in Northern France and abroad. We bring together environmental and business expertise in a "one stop shop"​ for environmental projects. We work in partnership with regional development organisations, business support structures, industry peak bodies and international …

The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players !

[Automatic translation follows] The information and meeting network for professionals in the sustainable construction and city sector The first European portal for construction and sustainable development professionals, Construction 21 is an open collaborative platform, available to French players to make their know-how and actions visible in France and Europe. This tool of general interest thus contributes to the dissemination of best practices in construction and sustainable development. Funded by the European Union and actively supported by France GBC, Construction21 is available in 7 languages ​​(French, English, Italian, German, Spanish, Lithuanian and Romanian). All concerned!!! Whether you are Architects, Project Owners, …

Sectors: Construction Media

Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is …

Sectors: Biotechnology

[Automatic translation follows] Official LinkedIn page of France Travail #OnEstLàPourVous #avecFranceTravail France Travail is a major player in the employment market in France where it is investing in facilitating the return to work of job seekers and offering companies solutions tailored to their recruitment needs. France Travail's 55,000 employees work daily to be the link between job seekers and businesses. France Travail is a key player in the French employment market. Its role is to help the unemployed find work and support companies to fulfill their recruitment requirements. Day-to-day, France Travail's 55,000 staff provides that vital link between job seekers …

Sectors: Human ressources

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care

Sectors: Pharmaceutical

[Automatic translation follows] Welcome to the page of the Ministry of Economy, Finance and Industrial and Digital Sovereignty Within the Ministry, more than 135,000 agents today put their talent at the service of a strong and sustainable economy in the region and in Paris. User service, legal affairs, economic development, performance management... more than 160 professions are carried out in the Bercy administrations. The diversity of these sectors of activity makes it possible to build rich career paths adapted to each person’s profiles. How to reach Bercy services? Each year, the ministry recruits 5,000 women and men. Numerous competitions of …

We are dedicated to therapeutic progress to serve patient needs. Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and …

Sectors: Pharmaceutical